anti phosphorylated pkc (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
anti phosphorylated pkc
Anti Phosphorylated Pkc, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 340 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+pkc%CE%B1/Phospho-PKC+(pan)+(betaII+Ser660)+Antibody/pm42810528-62-51-54
Average 96 stars, based on 340 article reviews
Anti Phosphorylated Pkc, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 340 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phospho+pkc%CE%B1/Phospho-PKC+(pan)+(betaII+Ser660)+Antibody/pm42810528-62-51-54
Average 96 stars, based on 340 article reviews
anti phosphorylated pkc - by Bioz Stars,
2026-11
96/100 stars
Images
Related Articles
Phospho-proteomics:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Expressing:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Quantitative Proteomics:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Transfection:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Control:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Fluorescence:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Negative Control:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Binding Assay:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Mutagenesis:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Luciferase:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Activity Assay:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Plasmid Preparation:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). Incubation:Article Title: Anchorage independence altered vasculogenic phenotype of melanoma cells through downregulation in aminopeptidase N /syndecan-1/integrin β4 axis Article Snippet: The primary antibodies against integrin α6 and integrin β2 were from Bioss antibodies Inc. (Woburn, Massachusetts, USA). |
